Table 5 Prevalence of symptoms and tumor markers as related to tumor malignancy and stage
Malignant | Benign | OR (95% CI) | ||||||
|---|---|---|---|---|---|---|---|---|
Stage I | Stage II-IV | All | (n = 116) | All malignant | Stage I | Stage II-IV | Stage II-IV | |
(n = 32) | (n = 28) | (n = 60) | vs. benign | vs. benign | vs. benign | vs. stage I | ||
Cluster | % | % | % | % | ||||
Abdomen | 72 | 64 | 68 | 31 | 4.7 (2.4 to 9.4) | 5.7 (2.4 to 13.5) | 4.0 (1.7 to 9.5) | 0.7 (0.2 to 2.1) |
Pain | 44 | 68 | 55 | 22 | 4.2 (2.1 to 8.2) | 2.7 (1.6 to 6.1) | 7.3 (2.9 to 18.1) | 2.7 (0.9 to 7.8) |
Eating | 37 | 54 | 45 | 12 | 6.0 (2.8 to 12.7) | 4.4 (1.8 to 10.8) | 8.4 (3.3 to 21.3) | 1.9 (0.7 to 5.4) |
Symptom index (SI) | 78 | 79 | 78 | 40 | 5.5 (2.7 to 11.3) | 5.4 (2.2 to 13.6) | 5.6 (2.1 to 14.8) | 1.0 (0.3 to 3.5) |
CA125 | 47 | 85 | 65 | 24 | 5.7 (2.8 to 12.2) | 3.5 (1.5 to 9.2) | 18.4 (5.4 to 79.4) | 5.1 (1.3 to 25.1) |
HE4 | 34 | 86 | 58 | 15 | 7.6 (3.7 to 15.6) | 2.8 (1.2 to 6.9) | 32.7 (10.1 to 105.4) | 11.4 (3.2 to 41.4) |
ROMA PI | 34 | 82 | 57 | 12 | 9.5 (4.4 to 20.3) | 3.8 (1.5 to 9.6) | 33.5 (11.0 to 102.4) | 8.7 (2.6 to 29.5) |